作者: A. Forner , J. M. Llovet
DOI: 10.1007/978-1-4020-8767-7_24
关键词:
摘要: In the past two decades hepatocellular carcinoma (HCC) has experienced a progressive increase in its incidence, at present constituting sixth most common cancer worldwide, third cause of cancer-related mortality1 and main death among cirrhotic patients.2 These facts are mostly due to long-term impact chronic hepatitis C virus (HCV) infection, along with early detection.3